5LWP

Discovery of phenoxyindazoles and phenylthioindazoles as RORg inverse agonists


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.253 
  • R-Value Work: 0.200 
  • R-Value Observed: 0.203 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history


Literature

Discovery of phenoxyindazoles and phenylthioindazoles as ROR gamma inverse agonists.

Ouvry, G.Bouix-Peter, C.Ciesielski, F.Chantalat, L.Christin, O.Comino, C.Duvert, D.Feret, C.Harris, C.S.Lamy, L.Luzy, A.P.Musicki, B.Orfila, D.Pascau, J.Parnet, V.Perrin, A.Pierre, R.Polge, G.Raffin, C.Rival, Y.Taquet, N.Thoreau, E.Hennequin, L.F.

(2016) Bioorg Med Chem Lett 26: 5802-5808

  • DOI: https://doi.org/10.1016/j.bmcl.2016.10.023
  • Primary Citation of Related Structures:  
    5LWP

  • PubMed Abstract: 

    Targeting the IL17 pathway and more specifically the nuclear receptor RORγ is thought to be beneficial in multiple skin disorders. The Letter describes the discovery of phenoxyindazoles and thiophenoxy indazoles as potent RORγ inverse agonists. Optimization of the potency and efforts to mitigate the phototoxic liability of the series are presented. Finally, crystallization of the lead compound revealed that the series bound to an allosteric site of the nuclear receptor. Such compounds could be useful as tool compounds for understanding the impact of topical treatment on skin disease models.


  • Organizational Affiliation

    Galderma R&D, Les Templiers 2400 Route des Colles, 06410 Biot, France.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Nuclear receptor ROR-gamma244Homo sapiensMutation(s): 0 
Gene Names: RORCNR1F3RORGRZRG
UniProt & NIH Common Fund Data Resources
Find proteins for P51449 (Homo sapiens)
Explore P51449 
Go to UniProtKB:  P51449
PHAROS:  P51449
GTEx:  ENSG00000143365 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP51449
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
79U
Query on 79U

Download Ideal Coordinates CCD File 
B [auth A]4-[3-[2-chloranyl-6-(trifluoromethyl)phenoxy]-5-(dimethylcarbamoyl)indazol-1-yl]benzoic acid
C24 H17 Cl F3 N3 O4
PRFOAGMHUSKCKE-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
79U BindingDB:  5LWP IC50: min: 31, max: 40 (nM) from 2 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.253 
  • R-Value Work: 0.200 
  • R-Value Observed: 0.203 
  • Space Group: H 3 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 173.81α = 90
b = 173.81β = 90
c = 68.4γ = 120
Software Package:
Software NamePurpose
XSCALEdata scaling
PHASERphasing
REFMACrefinement
PDB_EXTRACTdata extraction
XDSdata reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2016-11-16
    Type: Initial release
  • Version 1.1: 2016-12-07
    Changes: Database references
  • Version 1.2: 2024-01-17
    Changes: Data collection, Database references, Refinement description